临床外科杂志 ›› 2021, Vol. 29 ›› Issue (2): 140-142.doi: 10.3969/j.issn.1005-6483.2021.02.012

• • 上一篇    下一篇

全胸腔镜手术对肺癌病人的肿瘤标志物神经元特异烯醇化酶、降钙素原、CD3+、CD4+和CD8+的影响

  

  1. 安徽医科大学第一附属医院胸外科  
  • 出版日期:2021-02-20 发布日期:2021-02-20

Effect of total thoracoscopic surgery on tumor markers NSE,PCT,immune markers CD3+,CD4+ and CD8+ in lung cancer patients and its correlation with prognosis

  • Online:2021-02-20 Published:2021-02-20

摘要: 目的:探讨全胸腔镜手术对肺癌病人神经元特异烯醇化酶(neuronspecific enolase,NSE)、降钙素原(procalcitonin,PCT)、CD3+、CD4+和CD8+的影响及与预后的相关性。方法:2016年10月~2018年2月我院行全胸腔镜手术的肺癌病人85例为观察组;同期来我院进行检查的102例健康人为对照组。采用电化学免疫发光法检测观察组病人手术前后以及对照组血清NSE和PCT水平,采用全自动流式细胞仪检测观察组病人手术前后及对照组CD3+、CD4+和CD8+水平。结果:观察组病人手术前后NSE、PCT水平均高于对照组,但与术前比较,术后NSE、PCT水平均显著降低,差异有统计学意义(P<0.05);观察组病人手术前后CD8+比例均高于对照组,而CD3+、CD4+和CD4+/CD8+比例低于对照组,与术前比较,术后病人CD3+、CD4+和CD4+/CD8+比例均显著升高,差异有统计学意义(P<0.05)。二分类Logistic回归分析表明,NSEOR=3.32,95%CI=1.88~6.02,P=0.023),PCT(OR=8.12,95%CI=3.25~20.12,P=0.012),CD3+(OR=2.33,95%CI=1.52~7.92,P=0.021),CD4+(OR=5.53,95%CI=3.20~8.65,P=0.018)和CD4+/CD8+(OR=4.82,95%CI=1.57~8.51,P=0.015)是影响肺癌病人全胸腔镜手术预后的独立危险因素。结论:全胸腔镜手术可降低病人NSE和PCT水平,改善术后免疫功能。监测术后NSE、PCT、CD3+、CD4+和CD8+水平,对评估病人预后具有重要作用。

关键词: 全胸腔镜手术, 肺癌, 神经元特异烯醇化酶, 降钙素原, 免疫功能

Abstract: Objective:To investigate the effects of total thoracoscopic surgery on tumor specific neuron specific enolase(NSE),procalcitonin(PCT),immune markers CD3+,CD4+ and CD8+ in lung cancer patients and their correlation with prognosis.Methods:A total of 85 patients with lung cancer who underwent total thoracoscopic surgery in our hospital from October 2016 to February 2018 were selected as the observation group.102 healthy people who were enrolled in our hospital for the same period were selected as control group.The levels of serum NSE and PCT in the observation group before and after operation and in the control group were measured by electrochemiluminescence method.The levels of CD3+,CD4+ and CD8+ in the observation group before and after operation and in the control group were detected by automatic flow cytometry.Results:The NSE and PCT levels in the observation group were significantly higher than those in the control group before and after surgery,while the NSE and PCT levels after operation were significantly lower than those before surgery(P<0.05).The proportion of CD8+ before and after operation was significantly higher than that of the control group,while the proportions of CD3+,CD4+ and CD4+/CD8+ were significantly lower than those of the control group.Compared with preoperative,the proportions of CD3+,CD4+,and CD4+/CD8+ were significantly increased after surgery(P<0.05).The logistic regression analysis showed that NSE(OR=3.32,95%CI=1.88~6.02,P=0.023),PCT(OR=8.12,95%CI=3.25~20.12,P=0.012),CD3+(OR=2.33,95%CI=1.52~7.92,P=0.021),CD4+(OR=5.53,95%CI=3.20~8.65,P=0.018) and CD4+/CD8+(OR=4.82,95%CI=1.57~8.51,P=0.015) were independent risk factor for the prognosis of lung cancer patients undergoing thoracoscopic surgery.Conclusion:The total thoracoscopic surgery can effectively reduce the levels of NSE and PCT,improve postoperative immune function,and monitor the levels of NSE,PCT,CD3+,CD4+ and CD8+ after operation has an important role in assessing the prognosis of lung cancer.

Key words: total thoracoscopic surgery, lung cancer, neuronspecific enolase, procalcitonin, immune function

[1] 冯浩洁 姚颐 耿庆. 美国国家综合癌症网络临床实践指南:非小细胞肺癌(2021V1)更新解读[J]. 临床外科杂志, 2021, 29(1): 25-28.
[2] 周超 李文涛 王瑞 方文涛. 双镜联合治疗同时性多原发肺癌13例临床分析[J]. 临床外科杂志, 2021, 29(1): 38-41.
[3] 黎增亮 潘宴青 马国栋. 实性影/占位总径比率在肺多发性磨玻璃样结节术后的预后价值[J]. 临床外科杂志, 2020, 28(9): 841-844.
[4] 袁野 金润森 李鹤成. 机器人手术在肺癌外科的现状和展望[J]. 临床外科杂志, 2020, 28(7): 601-604.
[5] 李宗元 陈晓烨 刘伦旭. 机器学习在肺癌外科的研究进展[J]. 临床外科杂志, 2020, 28(7): 605-607.
[6] 滕啸 胡坚. 非小细胞肺癌新辅助免疫治疗前景[J]. 临床外科杂志, 2020, 28(7): 608-610.
[7] 张帆 谭锋维 薛奇 高树庚. 免疫检查点抑制剂在非小细胞肺癌新辅助治疗中的现状[J]. 临床外科杂志, 2020, 28(7): 611-614.
[8] 傅睿 钟文昭. 外科在Ⅲ期非小细胞肺癌多学科综合治疗中的地位[J]. 临床外科杂志, 2020, 28(7): 615-617.
[9] 郭凡 孙大强. 肺癌合并冠心病行同期外科手术治疗的现状和展望[J]. 临床外科杂志, 2020, 28(7): 618-621.
[10] 朱余明 郑卉. 微创肺癌根治术进展与挑战[J]. 临床外科杂志, 2020, 28(7): 621-623.
[11] 钟云鹏 何建行 李树本. 无管化电视胸腔镜在肺癌手术中的应用[J]. 临床外科杂志, 2020, 28(7): 624-626.
[12] 汪训豪 申磊 戴希勇. 肺癌合并肺结核52例外科治疗临床分析[J]. 临床外科杂志, 2020, 28(7): 647-649.
[13] 邓宇 郝博 耿庆. 小细胞肺癌治疗现状及展望[J]. 临床外科杂志, 2020, 28(7): 696-699.
[14] 狄子杨, 唐强, 狄茂军等. 腹腔热灌注化疗治疗晚期结直肠癌的疗效分析[J]. 临床外科杂志, 2020, 28(5): 433-436.
[15] 曹鹏, 孔康乐, 韩鹏, 李樊, 邓豫, 吴亮, 赵波, 付向宁, 祖育昆 . 肺癌根治术后合并新型冠状病毒(2019-nCoV)肺炎一例[J]. 临床外科杂志, 2020, 28(2): 195-196.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 蔡逊 马丹丹 刘勇等. 腹腔镜Roux-en-Y胃旁路术治疗2型糖尿病及其并发症的临床疗效观察 [J]. 临床外科杂志, 2016, 24(4): 276 - 276 .
[2] 陈璐;王涛;王少刚等 . 94例精索扭转诊疗体会 [J]. 临床外科杂志, 2016, 24(6): 479 .
[3] 李华莉;蔡嵘;任刚等. 胃和小肠胃肠道间质瘤临床病理特征差异性分析[J]. 临床外科杂志, 2016, 24(8): 611 .
[4] 代文杰. 中国晚期乳腺癌诊治专家共识2016版要点解读[J]. 临床外科杂志, 2017, 25(1): 24 .
[5] 董丽琴;王小平;陈奎铭;等. 甲状腺结节消融的治疗[J]. 临床外科杂志, 2017, 25(2): 157 .
[6] 喻少敏;郭卫春. 二十二碳六烯酸在急性脊髓损伤后早期炎性反应中的作用[J]. 临床外科杂志, 2017, 25(4): 301 .
[7] 周凯亮;邹贤军;司徒光伟. 肛周脓肿术后体外培育牛黄盐水纱条填塞对患者局部组织中IL-6和IL-8的影响[J]. 临床外科杂志, 2017, 25(5): 387 .
[8] 张刚;周春献;韩旭等. 经颈内静脉隧道式PICC置管的临床应用[J]. 临床外科杂志, 2018, 26(4): 310 .
[9] 马也 陈建华 周大胜 胡群超 顾科. FOXM1及E钙黏蛋白在乳腺癌组织中的表达及其临床意义的研究[J]. 临床外科杂志, 2018, 26(11): 835 -838 .
[10] 庞松强, 罗功唐, 宋瑶. 3D与2D腹腔镜前列腺癌根治术治疗前列腺癌综合效果及并发症比较[J]. 临床外科杂志, 2019, 27(2): 109 -112 .